HRGN
Harvard Apparatus Regenerative Technology, Inc.
+0.05 (+2.17%)2.35USD500成交股數41.3M市值–本益比(近四季)42.1股價營收比+30.6%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 414K+31% | 226K+402% | 219K+271% | 123K+120% | 317K+456% | 45K | 59K+48% | 56K | 57K | – | 40K | – |
| 營業成本 | 391K | 206K | 199K | 112K | 302K | 33K | 70K | 13K | 12K | – | – | – |
| 毛利 | 23K+53% | 20K+67% | 20K-282% | 11K-74% | 15K-67% | 12K | −11K | 43K | 45K | – | – | – |
| 毛利率 | 5.6% | 8.8% | 9.1% | 8.9% | 4.7% | 26.7% | -18.6% | 76.8% | 78.9% | – | – | – |
| 研發費用 | 948K | 563K | 700K | 655K | 697K | 601K | 557K | 642K | 840K | 648K | 339K | 1.6M |
| 銷售管理費用 | 751K | 1.0M | 986K | 1.0M | 1.2M | 1.1M | 1.1M | 1.7M | 1.1M | 1.1M | 1.2M | 1.1M |
| 營業利益 | −1.7M-8% | −1.6M-4% | −1.7M-9% | −1.7M-31% | −1.8M-9% | −1.7M-9% | −1.9M+14% | −2.5M-6% | −2.0M | −1.8M | −1.6M | −2.7M |
| 營業利益率 | -408.7% | -710.6% | -775.3% | -1,393.5% | -578.2% | -3,711.1% | -3,150.8% | -4,430.4% | -3,545.6% | – | -4,060.0% | – |
| 稅後淨利 | −1.7M-7% | −1.6M-3% | −1.7M-9% | −1.7M-32% | −1.8M-10% | −1.7M-13% | −1.9M+15% | −2.5M-4% | −2.0M | −1.9M | −1.6M | −2.6M |
| 淨利率 | -409.4% | -708.4% | -770.3% | -1,382.1% | -575.1% | -3,686.7% | -3,152.5% | -4,460.7% | -3,561.4% | – | -4,037.5% | – |
| 稀釋 EPS | – | – | – | – | – | – | -0.120% | -0.18-5% | -0.15 | -0.12 | -0.12 | -0.19 |
| 稀釋股數 | – | – | – | – | – | – | 15.0M | 14.3M | 13.9M | 13.5M | 13.9M | 13.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 351K | 419K | 1.4M | 1.3M | 786K | 1.7M | 3.6M | 139K | 272K | 432K | 269K | 2.1M |
| 應收帳款 | 9K | 16K | 16K | 3K | 5K | 4K | 1K | – | 7K | 4K | 3K | – |
| 存貨 | 0.00 | 15K | 16K | 22K | 27K | 48K | 113K | 60K | 44K | 50K | 56K | – |
| 總資產 | 1.7M | 1.8M | 2.7M | 2.5M | 2.1M | 3.4M | 5.3M | 4.4M | 4.4M | 2.6M | 3.8M | 5.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.1M | 1.7M | 1.6M | 992K | 1.4M | 1.4M | 1.5M | 2.0M | – | 968K | 1.1M | 2.0M |
| 股東權益 | −1.4M | 92K | 1.1M | 1.6M | 761K | 2.0M | 3.8M | −290K | 175K | 1.6M | 2.7M | 3.8M |
| 負債比 | 181.8% | 94.9% | 60.5% | 39.0% | 64.4% | 40.0% | 27.7% | 45.5% | – | 37.0% | 28.2% | 34.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −937K+24% | – | – | – | −758K | – | – | −960K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 704K
| Consumer Health Products | 704K | 100.0% | +63.7% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 704K | +63.7% | −6.9M | -975.7% | – | – |
| FY2024 | 430K | +317.5% | −7.7M | -1,798.1% | – | −4.9M |
| FY2023 | 103K | – | −9.0M | -8,759.2% | -0.67 | −7.0M |
| FY2022 | – | – | −6.1M | –% | -0.55 | −5.1M |
| FY2021 | 0.00 | – | −8.0M | –% | -0.79 | −2.6M |
| FY2020 | 0.00 | – | −4.9M | –% | -0.55 | −4.0M |
| FY2019 | 0.00 | – | −8.3M | –% | -1.21 | −6.2M |
| FY2018 | 0.00 | – | −7.5M | –% | -1.69 | −7.8M |